ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Administration of mesenchymal stem cells in diabetic kidney disease: a systematic review and meta-analysis

Lin, Wenshan; Li, Hong-Yan; Yang, Qian; Chen, Guangyong; Lin, Shujun; Liao, Chunling; Zhou, Tianbiao*南方医科大学; 汕头大学
Stem Cell Research & Therapy2021-1-7DOI: 10.1186/s13287-020-02108-5
11被引7阅读
引用收藏
分享

摘要

Background: Mesenchymal stem cell (MSC) therapy shows great promise for diabetic kidney disease (DKD) patients. Research has been carried out on this topic in recent years. The main goals of this paper are to evaluate the therapeutic effects of MSCs on DKD through a meta-analysis and address the mechanism through a systematic review of the literature. @@@ Method: An electronic search of the Embase, Cochrane Library, ISI Web of Science, PubMed, and US National Library of Medicine (NLM) databases was performed for all articles about MSC therapy for DKD, without species limitations, up to January 2020. Data were pooled for analysis with Stata SE 12. @@@ Result: The MSC-treated group showed a large and statistically significant hypoglycemic effect at 1week, 2weeks, 3weeks, 1month, 2months, 3months, and 6months. Total hypoglycemic effect was observed (SMD=-1.954, 95%CI -2.389 to -1.519, p<0.001; I-2 =85.1%). The overall effects on serum creatinine (SCr) and blood urea nitrogen (BUN) were analyzed, suggesting that MSC decreased SCr and BUN and mitigated the impairment of renal SCr: SMD=-4.838, 95%CI -6.789 to -2.887, p<0.001; I-2 =90.8%; BUN: SMD=-4.912, 95%CI -6.402 to -3.422, p<0.001; I-2 =89.3%). Furthermore, MSC therapy decreased the excretion of urinary albumin. Fibrosis indicators were assessed, and the results showed that transforming growth factor-beta, collagen I, fibronectin, and alpha-smooth muscle actin were significantly decreased in the MSC-treated group compared to the control group. @@@ Conclusion: MSCs might improve glycemic control and reduce SCr, BUN, and urinary protein. MSCs can also alleviate renal fibrosis. MSC therapy might be a potential treatment for DKD.

学科与关键词

关键词
Mesenchymal stem cellDiabetic kidney diseaseAnimal studyClinical trialMeta-analysisSystematic review
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Stem Cell Research & Therapy
发表日期
2021-01-07
卷期
第 12 卷, 第 1 期
页码
43
DOI
10.1186/s13287-020-02108-5
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Guangdong Medical Science and Technology Research Fund Project [A2018336]

作者

  • L

    Lin, Wenshan (第一作者)

    2 · shantou univ

  • L

    Li, Hong-Yan

    southern med univ

查看全部 7 位作者收起作者
  • Y

    Yang, Qian

    2 · shantou univ

  • C

    Chen, Guangyong

    2 · shantou univ

  • L

    Lin, Shujun

    2 · shantou univ

  • L

    Liao, Chunling

    2 · shantou univ

  • Z

    Zhou, Tianbiao (通讯)

    2 · shantou univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417